Home/Filings/4/0001358403-19-000077
4//SEC Filing

Foster Aaron E. 4

Accession 0001358403-19-000077

CIK 0001358403other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 4:57 PM ET

Size

5.5 KB

Accession

0001358403-19-000077

Insider Transaction Report

Form 4
Period: 2019-06-11
Foster Aaron E.
Sr VP, Head of Research
Transactions
  • Award

    Stock Option (right to buy)

    2019-06-11+50,00050,000 total
    Exercise: $1.87Exp: 2029-06-10Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the stock option vest and become exercisable on January 1, 2020, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1
  • filerCIK 0001767877

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 4:57 PM ET
Size
5.5 KB